This title is rewritten as: ETF betting heavily on weight loss medications from Eli Lilly and Novo Nordisk.
A leading provider of exchange-traded funds, Roundhill Investments, is wagering on the enduring appeal of GLP-1 weight loss medications.Last week, ...
